REDOXIS
Live / Registered — Registered (as of 03 Mar 2020)
What this means for you
Registered since 03 Mar 2020. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 88381396
- Registration number
- 6000250
- Mark type
- Word mark
- Filed
- 11 Apr 2019
- Published for opposition
- 17 Dec 2019
- Registered
- 03 Mar 2020
- Attorney of record
- Karen Kreider Gaunt
Goods and services
- Class 042 — Scientific and technological services: Medical research; biological research, clinical research in the field of pharmaceuticals and medical research; pharmaceutical research services; research on the subject of pharmaceuticals; scientific research in the field of pharmacy; pharmaceutical research and development services; research and development in the pharmaceutical and biotechnology fields; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; pharmaceutical drug development services; conducting early evaluations in the field of new pharmaceuticals; medical laboratory services; laboratory research services relating to pharmaceuticals
Owner
- Redoxis AB, Lund, SE
- Redoxis AB, Lund, SE
- Redoxis AB, Lund, SE
Prosecution history
- 03 Mar 2025 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 03 Mar 2020 — REGISTERED-PRINCIPAL REGISTER
- 17 Dec 2019 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 17 Dec 2019 — PUBLISHED FOR OPPOSITION
- 27 Nov 2019 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 12 Nov 2019 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 07 Nov 2019 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 07 Nov 2019 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 31 Oct 2019 — ASSIGNED TO LIE
- 25 Oct 2019 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 25 Jun 2019 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 25 Jun 2019 — NON-FINAL ACTION E-MAILED
- 25 Jun 2019 — NON-FINAL ACTION WRITTEN
- 21 Jun 2019 — ASSIGNED TO EXAMINER
- 29 Apr 2019 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED